COVID-19: The therapeutic landscape.

Area of Science:

• Infectious Diseases
• Clinical Research Methodology
• Pharmacology

Background:

• Hospitalized patients with COVID-19 required rapid therapeutic identification.
• Existing research highlighted critical lessons for effective clinical trial design and data interpretation.

Purpose of the Study:

• To summarize key lessons learned from the therapeutic research response for hospitalized COVID-19 patients.
• To advocate for the application of these lessons to the outpatient COVID-19 research setting.

Main Methods:

• Analysis of therapeutic research outcomes in hospitalized COVID-19 patients.
• Identification of recurring challenges and successful strategies in clinical trial execution.

Main Results:

• Clinical trial data is essential for guiding therapeutic use in COVID-19.
• Extrapolation of results between different disease stages (e.g., inpatient vs. outpatient) is not recommended.
• Study designs must prioritize clinically relevant data collection.

Conclusions:

• The principles guiding inpatient COVID-19 therapeutic research are transferable and essential for outpatient settings.
• Future research for non-hospitalized COVID-19 patients should incorporate these evidence-based methodological standards.